Millipore Sigma Vibrant Logo

569396 InSolution™ Staurosporine, Streptomyces sp.

InSolution™ Staurosporine, Streptomyces sp. CAS 62996-74-1, is provided as a 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569397) in DMSO

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: MLCK Inhibitor I, PKA Inhibitor II

Primary Target: PKA
View Products on Sigmaaldrich.com
569396
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
62996-74-1C₂₈H₂₆N₄O₃

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
569396-100UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      Catalogue Number569396
      Brand Family Calbiochem®
      SynonymsMLCK Inhibitor I, PKA Inhibitor II
      References
      ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
      Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
      Bruno, S., et al. 1992. Cancer Res. 52, 470.
      Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
      Vitale, M.L., et al. 1992. Neuroscience 51, 463.
      Hoffman, R. and Newland, E.S. 1991. Cancer Chemotherap. Pharmacol. 28, 102.
      Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
      Product Information
      CAS number62996-74-1
      ATP CompetitiveY
      FormLiquid
      FormulationA 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569397) in DMSO.
      Hill FormulaC₂₈H₂₆N₄O₃
      Chemical formulaC₂₈H₂₆N₄O₃
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationInSolution™ Staurosporine, Streptomyces sp. CAS 62996-74-1, is provided as a 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569397) in DMSO
      Biological Information
      Primary TargetPKA
      Primary Target IC<sub>50</sub>7 nM, 20 nM, 1.3 nM, 700 pM, 8.5 nM, against protein kinase A , CaM kinase, myosin light chain kinase, protein kinase C, and protein kinase G, respectively
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/38

      Irritating to eyes and skin.
      S PhraseS: 26

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Irritant
      Storage ≤ -70°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot, purge with inert gas, and freeze (-70°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      569396-100UG 07790788051693

      Documentation

      Licencias necesarias

      Título
      CARTA DE USO GENERAL 2016
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      InSolution™ Staurosporine, Streptomyces sp. Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      InSolution™ Staurosporine, Streptomyces sp. Certificados de análisis

      CargoNúmero de lote
      569396

      Referencias bibliográficas

      Visión general referencias
      Couldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
      Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
      Bruno, S., et al. 1992. Cancer Res. 52, 470.
      Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
      Vitale, M.L., et al. 1992. Neuroscience 51, 463.
      Hoffman, R. and Newland, E.S. 1991. Cancer Chemotherap. Pharmacol. 28, 102.
      Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.

      Citas

      Título
    • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
    • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
      		•
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-July-2008 JSW
      SynonymsMLCK Inhibitor I, PKA Inhibitor II
      DescriptionA potent, cell-permeable broad spectrum inhibitor of protein kinases. Inhibits CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase A (IC50 = 7 nM), protein kinase C (IC50 = 0.7 nM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint.
      FormLiquid
      FormulationA 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569397) in DMSO.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number62996-74-1
      Chemical formulaC₂₈H₂₆N₄O₃
      Structure formulaStructure formula
      Purity≥97% by HPLC
      Storage Protect from light
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot, purge with inert gas, and freeze (-70°C).
      Toxicity Irritant
      ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
      Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
      Bruno, S., et al. 1992. Cancer Res. 52, 470.
      Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
      Vitale, M.L., et al. 1992. Neuroscience 51, 463.
      Hoffman, R. and Newland, E.S. 1991. Cancer Chemotherap. Pharmacol. 28, 102.
      Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
      Citation
    • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
    • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
      		•